Lung and Heart-Lung Transplantation: Overview of Results

Elbert P. Trulock

doi:10.1055/s-2001-18420

Seminars in Respiratory and Critical Care Medicine, Table of Contents

Semin Respir Crit Care Med 2001; 22(5): 479-488
DOI: 10.1055/s-2001-18420

Lung and Heart-Lung Transplantation: Overview of Results

Elbert P. Trulock

Division of Pulmonary and Critical Care Medicine, Washington University School of Medicine, St. Louis, Missouri, and Lung Transplantation Program, Barnes-Jewish Hospital, St. Louis, Missouri

Abstract

ABSTRACT

During the last decade, activity in lung transplantation increased rapidly to a plateau of approximately 900 transplants per year in the United States, and it is unlikely to increase further unless the supply of useable donor organs can be expanded. However, the demand for lung transplantation has continued to rise, and the median waiting time for lung transplantation in the United States is approaching 2 years. The main indications for lung transplantation have been chronic obstructive pulmonary disease, α₁-antitrypsin deficiency emphysema, cystic fibrosis, idiopathic pulmonary fibrosis, primary pulmonary hypertension, and Eisenmenger's syndrome. Overall, survival after lung transplantation has been good, with 1-, 3-, and 5-year survival rates of 75, 58, and 44%, respectively, and the results have been improving. Chronic rejection and infection have been the main causes of medium-term mortality, and the high prevalence of chronic rejection remains a barrier to better outcomes. Quality of life has been enhanced by lung transplantation, but the posttransplantation immunosuppressive regimen has been associated with considerable morbidity.

KEYWORD

Lung transplantation - organ allocation - lung transplant activity - lung transplant outcomes

Full Text

References

REFERENCES

1 1999 Annual Report of the US Scientific Registry for Transplant Recipients and the Organ Procurement and Transplantation Network: Transplant Data: 1989-1998. US Dept of Health and Human Services, Health Resources and Services Administration, Office of Special Programs, Division of Transplantation, Rockville, MD; UNOS, Richmond, VA; 1999
2 United Network for Organ Sharing (UNOS) data. Available at: http://www.unos.org/frame_default.asp
3 Hosenpud J D, Bennett L E, Keck B M, Boucek M M, Novick R J. The Registry of the International Society for Heart and Lung Transplantation: seventeenth official report-2000. J Heart Lung Transplant . 2000; 19 909-931
4 ISHLT Seventeenth Annual Data Report, April 2000. Available at: http://www.ishlt.org/regist_heart-lung_report_toc.htm
5 Evans R W, Orians C E, Ascher N L. The potential supply of donor organs: an assessment of the efficiency of organ procurement efforts in the United States. JAMA . 1992; 267 239-246
6 1994 Annual Report of the US Scientific Registry for Transplant Recipients and the Organ Procurement and Transplantation Network-Transplant Data: 1988-1993. UNOS, Richmond, VA, and the Division of Organ Transplantation, Bureau of Health Resources Development, Health Resources and Services Administration, US Dept of Health and Human Services, Bethesda, MD; 1994
7 Organ Procurement and Transplantation Network: final rule. 42 CFR Part 121. Federal Register 1998 63(no. 63): 16296-16338
8 Organ Procurement and Transplantation Network: final rule. 42 CFR Part 121. Federal Register 1998 64(no. 202): 56650-56661
9 Hayden A M, Robert R C, Kriett J M, Smith C M, Nicholson K, Jamieson S W. Primary diagnosis predicts prognosis of lung transplant candidates. Transplantation . 1993; 55 1048-1050
10 Kadikar A, Maurer J, Kesten S. The six-minute walk test: a guide to assessment for lung transplantation. J Heart Lung Transplant . 1997; 16 313-319
11 D'Armini A M, Callegari G, Vitulo P. Risk factors for early death in patients awaiting heart-lung or lung transplantation. Transplantation . 1998; 66 123-127
12 Hosenpud J D, Bennett L E, Keck B M, Edwards E B, Novick R J. Effect of diagnosis on survival benefit of lung transplantation for end-stage lung disease. Lancet . 1998; 351 24-27
13 Geertsma A, TenVergert E M, Bonsel G J, de Boer J W, van der Bij W. Does lung transplantation prolong life?. <~>A comparison with and without transplantation. J Heart Lung Transplant . 1998; 17 511-516
14 UNOS data obtained by request. Communication from Leah Bennett, Ph.D. UNOS, Richmond, VA. Received on September 29, 2000
15 Levine S M, Bryan C L. Bronchiolitis obliterans in lung transplant recipients: the ``thorn in the side'' of lung transplantation. Chest . 1995; 107 894-897
16 Cooper J D, Billingham M, Egan T. A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allografts. J Heart Lung Transplant . 1993; 12 713-716
17 Trulock E P. Flexible bronchoscopy in lung transplantation. Clin Chest Med . 1999; 20 77-87
18 Bando K, Paradis I L, Similo S. Obliterative bronchiolitis after lung and heart-lung transplantation: an analysis of risk factors and management. J Thorac Cardiovasc Surg . 1995; 110 4-14
19 Girgis R A, Tu I, Berry G J. Risk factors for the development of obliterative bronchiolitis after lung transplantation. J Heart Lung Transplant . 1996; 15 1200-1208
20 Sharples L D, Tamm M, McNeil K, Higenbottam T, Stewart S, Wallwork J. Development of bronchiolitis obliterans syndrome in recipients of heart-lung transplantation: early risk factors. Transplantation . 1996; 61 560-566
21 Hussain A N, Siddiqui M T, Holmes E W. Analysis of risk factors for the development of bronchiolitis obliterans. Am J Respir Crit Care Med . 1999; 159 829-833
22 Kroshus T J, Kshettry V R, Savik K, John R, Hertz M I, Bolman III M R. Risk factors for the development of bronchiolitis obliterans syndrome after lung transplantation. J Thorac Cardiovasc Surg . 1997; 114 195-202
23 Valentine V G, Robbins R C, Berry G J. Actuarial survival of heart-lung and bilateral sequential lung transplant recipients with obliterative bronchiolitis. J Heart Lung Transplant . 1996; 15 371-383
24 Maurer J R, Tewari S. Nonpulmonary medical complications in the intermediate and long-term survivor. Clin Chest Med . 1997; 18 367-382
25 Epstein S. Post-transplantation bone disease: the role of immunosuppressive agents and the skeleton. J Bone Miner Res . 1996; 11 1-7
26 Aris R M, Neuringer I P, Weiner M A, Egan T M, Ontjes D. Severe osteoporosis before and after lung transplantation. Chest . 1996; 109 1176-1183
27 Shane E, Papadopoulos A, Staron R B. Bone loss and fracture after lung transplantation. Transplantation . 1999; 68 220-227
28 Penn I. Neoplastic complications of organ transplantation. In: Ginns LC, Cosimi AB, Morris PJ, eds. Transplantation Malden, MA: Blackwell Science Inc 1999: 770-786
29 Trulock E P. State of the art: lung transplantation. Am J Respir Crit Care Med . 1997; 155 789-818
30 Howard D A, Iademarco E, Trulock E P. The role of cardiopulmonary exercise testing in lung and heart-lung transplantation. Clin Chest Med . 1994; 15 405-420
31 Schwaiblmair M, Reichenspurner H, Muller C. Cardiopulmonary exercise testing before and after lung and heart-lung transplantation. Am J Respir Crit Care Med . 1999; 159 1277-1283
32 Wang X N, Williams T J, McKenna M J. Skeletal muscle oxidative capacity, fiber type, and metabolites after lung transplantation. Am J Respir Crit Care Med . 1999; 160 57-63
33 Lands L C, Smountas A A, Mesianno G. Maximal exercise capacity and peripheral skeletal muscle function following lung transplantation. J Heart Lung Transplant . 1999; 18 113-120
34 Ramsey S D, Patrick D L, Lewis S, Albert R K, Raghu G, and the University of Washington Lung Transplant Study Group. Improvement in quality of life after lung transplantation: a preliminary study. J Heart Lung Transplant . 1995; 14 870-877
35 Gross C, Savik K, Bolman R M, Hertz M I. Long-term health status and quality of life outcomes of lung transplant recipients. Chest . 1995; 108 1587-1593
36 TenVergert E M, Essink-Bot M-L, Geertsma A, van Enckevort J P, de Boer J W, van der Bij W. The effect of lung transplantation on health-related quality of life: a longitudinal study. Chest . 1998; 113 358-364
37 van den Berg W K J, Geertsma A, van der Bij W. Bronchiolitis obliterans syndrome after lung transplantation and health-related quality of life. Am J Respir Crit Care Med . 2000; 161 1937-1941
38 Ramsey S D, Patrick D L, Albert R K, Larson E B, Wood D E, Raghu G. The cost-effectiveness of lung transplantation: a pilot study. Chest . 1995; 108 1594-1601
39 Lanuza D M, Lefavier C, McCabe M, Farcas G A, Garrity Jr E. Prospective study of functional status and quality of life before and after lung transplantation. Chest . 2000; 118 115-122
40 Gartner S H, Sevick M A, Keenan R J, Chen G J. Cost-utility of lung transplantation: a pilot study. J Heart Lung Transplant . 1997; 16 1129-1134